India’s pharmaceutical exports are nearing the USD 30-billion mark, setting the stage for the next phase of industry innovation powered by Contract Research and Development Organisations (CRDMOs) and Global Capability Centers (GCCs), according to a new EY-Parthenon-OPPI report. T







